Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer

被引：7

作者：

Boeck, Stefan ^{[1
]}

Geiger, Sandra ^{[1
]}

Schulz, Christoph ^{[1
]}

Heinernann, Volker ^{[1
]}

机构：

[1] Univ Munich, Dept Internal Med 3, Klinikum Grosshadern, Munich, Germany

来源：

JOURNAL OF CLINICAL GASTROENTEROLOGY | 2008年 / 42卷 / 05期

关键词：

D O I：

10.1097/MCG.0b013e31802da22e

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：551 / 552

页数：2

共 7 条

[1] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].

Burris, HA ;

Moore, MJ ;

Andersen, J ;

Green, MR ;

Rothenberg, ML ;

Madiano, MR ;

Cripps, MC ;

Portenoy, RK ;

Storniolo, AM ;

Tarassoff, P ;

Nelson, R ;

Dorr, FA ;

Stephens, CD ;

VanHoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413

[2]

Fung MC, 1999, CANCER-AM CANCER SOC, V85, P2023

[3] Gemcitabine-associated thrombotic microangiopathy [J].

Humphreys, BD ;

Sharman, JP ;

Henderson, JM ;

Clark, JW ;

Marks, PW ;

Rennke, HG ;

Zhu, AX ;

Magee, CC .

CANCER, 2004, 100 (12) :2664-2670

[4] Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate [J].

Lima, CMR ;

Green, MR ;

Rotche, R ;

Miller, WH ;

Jeffrey, GM ;

Cisar, LA ;

Morganti, A ;

Orlando, N ;

Gruia, G ;

Miller, LL .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3776-3783

[5] Gemcitabine and haemolytic-uraemic syndrome [J].

Ruiz, I ;

Del Valle, J ;

Gómez, A .

ANNALS OF ONCOLOGY, 2004, 15 (10) :1575-1576

[6]

Saif MW, 2005, J PANCREAS, V6, P369

[7] A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer [J].

Ueno, Hideki ;

Okusaka, Takuji ;

Funakoshi, Akihiro ;

Ishii, Hiroshi ;

Yamao, Kenji ;

Ishikawa, Osamu ;

Ohkawa, Shinichi ;

Saitoh, Soh .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) :447-454

← 1 →